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1. Introduction 
The use of endocytizable and lysosomotropic drugs 
is very promising in the chemotherapy of cancer [1 ], 
intracellular infection [2] and many other pathologi- 
cal processes [3]. Work in this direction has resulted 
in the development of complexes of anti-mitotic 
drugs with DNA [4], various proteins [5,6] and the 
entrapment ofvarious pharmacological agents in lipo- 
somes [7-10].  This paper describes a new type of 
lysosomotropic carrier, made of small capsules of 
plastomers, with a diameter of about 200 nm: nano- 
capsules. They can be used to entrap a variety of 
molecules in a stable and reproducible way [11]. In 
the experiments reported here, we have studied the 
preparation and the intracellular uptake and localiza- 
tion of nanocapsules made of polyacrylamide and 
loaded with fluorescein. 
2. Experimental nd results 
2.1. Preparation f polyacrylamide nanocapsules 
Nanocapsules were made by the micellar polymeri- 
zation method [11 ], in presence of sodium fluores- 
cein, as shown in scheme I. After washing and isolation 
of particles, nanocapsules contained 47/lg fluorescein/ 
mg polymer, i.e., 71% of the expected concentration. 
After ultrafiltration (Membrane UH 100, Schleicher 
und Shull, Ztirich) of a 0.1% suspension of nano- 
capsules in water, about 30% of the fluorescein 
remained frmly bound. The appearance of nano- 
capsules type A in the scanning electron microscope is
shown in fig.1. They present a spherical form, indicat- 
ing a satisfactory isolation procedure; their mean diam- 
eter is about 200 nm. Similar pictures were obtained 
for nanocapsules type B. The aggregation seen in the 
pictures results from the technique used for the prepa- 
ration of the sample; when nanocapsules are dispersed 
in water they form clear solutions and are not sedi- 
mented after centrifugation at 1.3 × 106 × g (Beckman 
J-21 centrifuge; rotor 20-J-A, operated at 20 000 rev/ 
rain). 
2.2. Uptake and in tracellular fate of entrapped 
fluorescein 
Cultured rat fibroblasts [12] were incubated with 
fluorescein-laden nanocapsules type A, at a concentra- 
tion of 1 mg polymer/ml, i.e., 47 ~tg encapsulated 
fluorescein. After 12 h, cells had accumulated 155 ng 
fluorescent material (expressed in terms of fluores- 
cein)/mg cell protein. In the fluorescence microscope, 
fluorescence was mainly seen in the form of numerous, 
discrete granules urrounding the nucleus, and of
appearance similar to that of lysosomes [13,14]. 
After isopycnic entrifugation f a cytoplasmic extract 
in sucrose gradient (fig.2), 2/3 fluorescent material 
showed a distribution pattern close to that of the lyso- 
somal enzyme N-acetyl-fl-glucosaminidase; the 
remaining I/3 was found in the top fractions of the 
gradient; complete dissociation was observed from 
5'-nucleotidase, a marker enzyme of plasma membranes 
and related structures. Since 1 mg cell protein corre- 
sponds to approx. 5/al, of which lysosomes represent 
only 3% [13[, the concentration f fluorescein i  lyso- 
somes can be calculated to be 15-fold larger than that 
in the culture medium, if it is distributed uniformly 
within these organelles. 
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Scheme 1 
Preparation scheme of polyacrylamide nanocapsules loaded with fluorescein 
December 1977 
Internal phase External phase 
Micellar 
Fluorescein 160 mg ~ Aerosol OT 12 g 
Water 8 ml LA 55-4 6 g 
Solubilisation 
n-Hexane 20 g 
+ n-Hexane 
ad 
l l0g  
T-Irradiation 
(0.5 Mrad) 
Isolation of 
the particles 
by distillation 
or  
+ 20 g n-Hexane 
[+2.25 g Acrylamide (Nanocapsutes A)
+2.0 g Acrylamide and 0.25 g 
NN'-methylenbisacrylamide 
(Nanocapsules B)
Precipitation of the polymer 
by acetone 
l 
Washing process: ultracentri- 
fugation of a dispersion of the 
nanocapsules in a mixed solution 
of acetone and n-hexane (7:3) 
Type A: linear polymer; Type B: branched polymer. (See [ 11] for details) 
By contrast, cells incubated with 50 tag/ml free 
fluorescein took up only 25 ng fluorescein/mg protein; 
under the microscope, the fluorescence was weak and 
diffuse over the whole cell body; after isopycnic 
centrifugation, fluorescent material was only collected 
in the top fractions, where neutral pyrophosphatase, 
a soluble enzyme of the cytoplasm, is found. 
3. Discussion 
Our results how that polyacrylamide nanocapsules 
of a diameter of 200 nm or less can satisfactorily be 
made to entrap and retain material of low molecular 
weight. Entrapment of fluorescein in nanocapsules 
significantly increases its uptake by cultured fibroblasts 
but more important, allows its association with and 
accumulation i to lysosomes, a cell compartment in 
which fluorescein does not spontaneously accumulate, 
probably because it is an organic acid [3]. Not all 
intracellular fluorescence is however confined to lyso- 
somes; this may result from the partial eakage of free 
fluorescein from the capsules, before or after uptake 
by cells. Access of encapsulated fluorescein to lyso- 
somes most probably occurs by endocytosis, ince 
this is the only route clearly described bywhich non- 
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Fig.1. Morphological appearance of nanocapsules type A (linear polyacrylamide) in the scanning electron microscope. Left: 
magnification 7055 X ; right: magnification 14 450 X, 
infectious particulate material can center mammalian 
cells to this extent. 
As such, polyacrylamide nanocapsules may 
represent an important step ahead into the development 
of lysosomotropic carriers for compounds that do not 
gain access to lysosomes [3]. They may also be useful 
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in promoting the cellular uptake via endocytosis of 
compounds that would normally diffuse through bio- 
logical membranes [ 141. In this respect, it is note- 
worthy that OUT results were obtained with cells that 
are not professional phagocytes. However, the polymer 
used in this preparation of nanocapsules is unlikely to 
N-acetyl-I3 
glucosamintdase 
Fluorescence 
Fig.2. Isopycnic centrifugation of cytoplasmic extracts of fibroblasts cultured 12 h in presence of free (broken line) or 
encapsulated (solid line) fluorescein. Results are expressed as normalized histograms, the total areas of which are equal to 1 (for 
methods see [ 121). As stated in text, encapsulation resulted into a 6.1-fold increase in the cellular concentration of fluorescent 
material. In a control experiment, where fluorescein-laden anocapsules were added to a cytoplasmic extract, after collection and 
homogenization of the cell, all fluorescent material was recovered above a density of 1.07 g/cm’. 
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be digested by lysosomal enzymes and this might 
restrict its use, since long-lasting overloading of lyso- 
somes could ensue. The design of digestible nano- 
capsules will therefore be investigated. 
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